Finnegan Score Calculator
Calculate a Finnegan score to help assess the severity of neonatal withdrawal symptoms.
Central Nervous System Signs
Metabolic, Vasomotor & Respiratory Signs
Gastrointestinal Signs
What Is the Finnegan Score?
The Finnegan Score is a standardized assessment tool used to evaluate the severity of neonatal abstinence syndrome (NAS). It quantifies withdrawal symptoms in newborns who were exposed to opioids or other substances during pregnancy. Each symptom is assigned a numerical value based on its severity, and the total score helps clinicians determine whether pharmacological intervention is needed.
This calculator implements the Finnegan Neonatal Abstinence Scoring System, allowing healthcare providers to quickly compute a total score from individual symptom observations.
How the Scoring System Works
The Finnegan system evaluates 31 discrete signs of withdrawal, grouped into categories such as central nervous system disturbances, metabolic/vasomotor/respiratory disturbances, and gastrointestinal disturbances. Each sign has a defined point value, typically ranging from 1 to 5 depending on severity.
Common scored symptoms include:
- High-pitched cry — scored 2 or 3 based on frequency and intensity
- Tremors — scored 1 to 4 depending on whether they occur when undisturbed or stimulated
- Increased muscle tone — scored 2
- Excoriation (skin breakdown) — scored 1 to 3
- Frequent yawning — scored 1
- Poor feeding — scored 1 to 3
- Vomiting or regurgitation — scored 2 or 3
- Loose or watery stools — scored 2 or 3
The total score is the sum of all individual symptom scores recorded during a single assessment period.
How to Use This Calculator
Select the appropriate score for each symptom category based on your clinical observation of the infant. The calculator automatically sums the values and displays the total Finnegan score. Scores are typically assessed every 3 to 4 hours, with the timing adjusted based on the infant's feeding schedule and clinical status.
For accurate scoring, observe the infant for the full assessment period before recording scores. Some symptoms, such as tremors or high-pitched cry, may require careful differentiation between mild and severe presentations.
Interpreting the Results
The total Finnegan score guides clinical decision-making. Common thresholds include:
- Score of 0–7 — Mild or no significant withdrawal symptoms. Non-pharmacological care (swaddling, frequent feeding, low-stimulation environment) is typically sufficient.
- Score of 8 or higher — Moderate to severe withdrawal. Pharmacological intervention (usually morphine or methadone) is often indicated, especially if scores remain elevated across consecutive assessments.
Some institutions use a threshold of 8 for two consecutive scores or 12 for a single score to initiate treatment. Always follow your institution's specific clinical protocol.
The score is one component of clinical assessment. It should be interpreted alongside the infant's overall clinical picture, gestational age, and feeding tolerance.
Common Scoring Considerations
Several factors can influence scoring accuracy:
- Inter-rater variability — Different observers may score the same infant differently. Regular training and standardized assessment protocols improve consistency.
- Timing of assessment — Scores can fluctuate based on feeding, handling, and time since last medication dose. Consistent timing improves reliability.
- Prematurity — Premature infants may exhibit different baseline behaviors, making it harder to distinguish withdrawal symptoms from normal developmental patterns.
- Polypharmacy exposure — Infants exposed to multiple substances may present with atypical symptom profiles that do not fit neatly into the scoring system.
Limitations of the Finnegan Score
The Finnegan scoring system was originally developed for opioid-exposed infants. Its validity for assessing withdrawal from other substances (such as benzodiazepines, antidepressants, or polysubstance exposure) is less well established. The scoring system is also subjective, relying on clinical observation rather than objective biomarkers.
Some institutions have adopted modified versions of the Finnegan score or alternative tools such as the Eat, Sleep, Console (ESC) approach, which focuses on functional assessment rather than symptom enumeration. This calculator uses the standard Finnegan scoring criteria.
Clinical Applications
The Finnegan score is used in neonatal intensive care units (NICUs), special care nurseries, and pediatric wards where infants with prenatal substance exposure are monitored. It supports:
- Standardized withdrawal assessment across nursing shifts
- Objective criteria for initiating and weaning pharmacological treatment
- Documentation of symptom progression over time
- Communication between healthcare providers about infant status
FAQ
What is a normal Finnegan score?
There is no single "normal" score. Scores below 8 are generally considered mild and are often managed with non-pharmacological care. Scores of 8 or higher typically indicate clinically significant withdrawal that may require medication.
How often should Finnegan scores be assessed?
Standard practice is to assess every 3 to 4 hours, timed around the infant's feeding schedule. More frequent assessments may be needed during medication weaning or if symptoms are rapidly changing.
Can the Finnegan score be used for non-opioid withdrawal?
The Finnegan system was designed for opioid-exposed infants. While it is sometimes used for other substances, its reliability for non-opioid withdrawal has not been rigorously validated. Alternative assessment tools may be more appropriate in those cases.
What score requires medication for NAS?
Most protocols initiate pharmacological treatment when the Finnegan score is 8 or higher on two consecutive assessments, or 12 or higher on a single assessment. However, thresholds vary by institution. Always follow your facility's specific clinical guidelines.
Is the Finnegan score still the standard of care?
The Finnegan score remains widely used, but some centers are transitioning to the Eat, Sleep, Console (ESC) approach, which emphasizes functional assessment. Both methods have evidence supporting their use, and the choice depends on institutional protocol and clinical context.